Updates from The Motley Fool

Latest updates on Navidea Biopharmaceuticals, Inc. from Fool.com.

Stock Performance

NAVB vs. S&P 500 | 2 Year Performance
NAVB 1-Day Stock Chart
NAVB 5-Day Stock Chart
NAVB 1-Month Stock Chart
NAVB 3-Month Stock Chart
NAVB 6-Month Stock Chart
NAVB 1-Year Stock Chart
NAVB 2-Year Stock Chart
NAVB 5-Year Stock Chart
View Interactive NAVB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Navidea Biopharmaceuticals, Inc..
Current Price: $0.88
Prev Close: $0.88
Open: $0.87
Bid: $0.85
Ask: $0.87
Day's Range: $0.85 - $0.88
52wk Range: $0.75 - $2.50
Volume: 911,148
Avg Vol 805,899
Market Cap: $137.00M
P/E (ttm): -4.19
EPS (ttm): -$0.21
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Navidea Biopharmaceuticals, Inc..
CAPS Rating 1 out of 5
88 Outperform
17 Underperform
CAPS All Stars
10 Outperform
7 Underperform

How do you think Navidea Biopharmaceuticals, Inc. will perform against the market?

You pick for Navidea Biopharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark J. Pykett, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Navidea Biopharmaceuticals, Inc..

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Healthcare IT